John C. Byrd
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research 508
- Hematology top 0.02%
- Acute Myeloid Leukemia Research 122
- Chronic Myeloid Leukemia Treatments 97
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment 228
- Immunology top 0.1%
- Immunodeficiency and Autoimmune Disorders 98
- Oncology top 0.2%
-
- Acute Lymphoblastic Leukemia research 82
-
- Monoclonal and Polyclonal Antibodies Research 64
-
- Advanced Breast Cancer Therapies 59
- Co-authors
- Amy J. JohnsonJennifer A. WoyachMichael R. GreverJoseph M. FlynnNyla A. HeeremaKristie A. BlumJeffrey A. JonesThomas J. Kipps
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
John C. Byrd
679 papers receiving 27.6k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Genetics 15.1k
- Hematology 9.3k
- Pathology and Forensic Medicine 10.6k
- Immunology 7.9k
- Oncology 6.4k
Countries citing papers authored by John C. Byrd
This map shows the geographic impact of John C. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Byrd more than expected).
Fields of papers citing papers by John C. Byrd
This network shows the impact of papers produced by John C. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Byrd. The network helps show where John C. Byrd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John C. Byrd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2022 | 20 | |
| 3 | 2020 | 27 | |
| 4 | 2020 | 126 | |
| 5 | 2020 | 57 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 144 | |
| 8 | 2016 | 121 | |
| 9 | 2016 | 16 | |
| 10 | 2016 | 21 | |
| 11 | 2014 | 198 | |
| 12 | 2013 | 31 | |
| 13 | 2013 | 151 | |
| 14 | 2013 | 110 | |
| 15 | 2013 | 19 | |
| 16 | 2012 | 53 | |
| 17 | 2011 | 102 | |
| 18 | 2010 | 71 | |
| 19 | 2008 | 117 | |
| 20 | 2007 | 256 |
About John C. Byrd
John C. Byrd is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 701 papers that have together received 28.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (508 papers), Lymphoma Diagnosis and Treatment (228 papers), Acute Myeloid Leukemia Research (122 papers), Immunodeficiency and Autoimmune Disorders (98 papers), Chronic Myeloid Leukemia Treatments (97 papers), Acute Lymphoblastic Leukemia research (82 papers), Monoclonal and Polyclonal Antibodies Research (64 papers) and Advanced Breast Cancer Therapies (59 papers). The work is most often cited by research in Genetics (15.1k citations), Hematology (9.3k citations) and Pathology and Forensic Medicine (10.6k citations). John C. Byrd has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Amy J. Johnson, Jennifer A. Woyach, Michael R. Grever, Joseph M. Flynn, Nyla A. Heerema, Kristie A. Blum, Jeffrey A. Jones, Thomas J. Kipps, Thomas S. Lin and Leslie A. Andritsos. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Clinical Cancer Research and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.